Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Nordin, Terri (57510130400)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Gastrointestinal tract disorders in older age
    (2019)
    Dumic, Igor (57200701725)
    ;
    Nordin, Terri (57510130400)
    ;
    Jecmenica, Mladen (57193452475)
    ;
    Stojkovic Lalosevic, Milica (57218133245)
    ;
    Milosavljevic, Tomica (7003788952)
    ;
    Milovanovic, Tamara (55695651200)
    Considering an increase in the life expectancy leading to a rise in the elderly population, it is important to recognize the changes that occur along the process of aging. Gastrointestinal (GI) changes in the elderly are common, and despite some GI disorders being more prevalent in the elderly, there is no GI disease that is limited to this age group. While some changes associated with aging GI system are physiologic, others are pathological and particularly more prevalent among those above age 65 years. This article reviews the most important GI disorders in the elderly that clinicians encounter on a daily basis. We highlight age-related changes of the oral cavity, esophagus, stomach, small and large bowels, and the clinical implications of these changes. We review epidemiology and pathophysiology of common diseases, especially as they relate to clinical manifestation in elderly. Details regarding management of specific disease are discussed in detail if they significantly differ from the management for younger groups or if they are associated with significant challenges due to side effects or polypharmacy. Cancers of GI tract are not included in the scope of this article. © 2019 Igor Dumic et al.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (Dress) syndrome: A systematic review of the literature
    (2021)
    Jevtic, Djordje (57220173102)
    ;
    Dumic, Igor (57200701725)
    ;
    Nordin, Terri (57510130400)
    ;
    Singh, Amteshwar (56587109100)
    ;
    Sulovic, Nadezda (57263952700)
    ;
    Radovanovic, Milan (57204113723)
    ;
    Jecmenica, Mladen (57193452475)
    ;
    Milovanovic, Tamara (55695651200)
    Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a potentially life threatening severe cutaneous drug reaction. Most patients develop eosinophilia, a rash, a fever, lymphadenopathy and variable visceral organ involvement 2–6 weeks following exposure to the inciting medication. Unlike other severe cutaneous drug reactions, internal organ involvement that leads to high mortality is a unique feature of DRESS syndrome. While the liver is the most common internal organ involved, literally every other visceral organ can be affected in this syndrome. The lesser-known gastrointestinal manifestations of this syndrome include esophagitis, gastritis, enteritis, colitis, pancreatitis and a late autoimmune sequela due to pancreatic injury such as fulminant type 1 diabetes mellitus, autoimmune type 1 diabetes mellitus and type 2 diabetes mellitus. While these entities are less common, they are associated with equally severe complications and adverse patient outcomes. In this review, we synthetize data on these rare manifestations using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The liver, the most common visceral organ involved, has been described as part of DRESS elsewhere and is not included in the scope of this article. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses /by/4.0/).
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Renal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of 71 Cases
    (2023)
    Dagnon da Silva, Marilia (58289608500)
    ;
    Domingues, Sidney Marcel (56850149200)
    ;
    Oluic, Stevan (57699015400)
    ;
    Radovanovic, Milan (57204113723)
    ;
    Kodela, Pratyusha (58512161100)
    ;
    Nordin, Terri (57510130400)
    ;
    Paulson, Margaret R. (57217125095)
    ;
    Joksimović, Bojan (56955484200)
    ;
    Adetimehin, Omobolanle (58418501200)
    ;
    Singh, Devender (58593573000)
    ;
    Madrid, Cristian (57217108516)
    ;
    Cardozo, Milena (57571248700)
    ;
    Baralic, Marko (56258718700)
    ;
    Dumic, Igor (57200701725)
    Unlike other adverse drug reactions, visceral organ involvement is a prominent feature of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and correlates with mortality. The aim of this study was to systematically review cases published in PubMed-indexed, peer-reviewed journals in which patients had renal injury during the episode of DRESS syndrome (DS). We found 71 cases, of which 67 were adults and 56% were males. Female sex was associated with higher mortality. Chronic kidney disease (CKD) was present in 14% of patients who developed acute kidney injury (AKI) during DS. In 21% of cases, the kidneys were the only visceral organ involved, while 54% of patients had both liver and kidney involvement. Eosinophilia was absent in 24% of patients. The most common classes of medication associated with renal injury in DS were antibiotics in 34%, xanthine oxidase inhibitors in 15%, and anticonvulsants in 11%. Among antibiotics, vancomycin was the most common culprit in 68% of patients. AKI was the most common renal manifestation reported in 96% of cases, while isolated proteinuria or hematuria was present in only 4% of cases. In cases with AKI, 88% had isolated increase in creatinine and decrease in glomerular filtration (GFR), 27% had AKI concomitantly with proteinuria, 18% had oliguria, and 13% had concomitant AKI with hematuria. Anuria was the rarest manifestation, occurring in only 4% of patients with DS. Temporary renal replacement therapy was needed in 30% of cases, and all but one patient fully recovered renal function. Mortality of DS in this cohort was 13%, which is higher than previously reported. Medication class, latency period, or pre-existing CKD were not found to be associated with higher mortality. More research, particularly prospective studies, is needed to better recognize the risks associated with renal injury in patients with DS. The development of disease-specific biomarkers would also be useful so DS with renal involvement can be easier distinguished from other eosinophilic diseases that might affect the kidney. © 2023 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Suppurative Thrombosis of the Portal Vein (Pylephlebits): A Systematic Review of Literature
    (2022)
    Jevtic, Dorde (57220173102)
    ;
    Gavrancic, Tatjana (55251798800)
    ;
    Pantic, Ivana (57223613349)
    ;
    Nordin, Terri (57510130400)
    ;
    Nordstrom, Charles W. (57211256255)
    ;
    Antic, Marina (57571622500)
    ;
    Pantic, Nikola (57221630977)
    ;
    Kaljevic, Marija (57571118400)
    ;
    Joksimovic, Bojan (56955484200)
    ;
    Jovanovic, Milan (58323711900)
    ;
    Petcu, Emilia (57854030000)
    ;
    Jecmenica, Mladen (57193452475)
    ;
    Milovanovic, Tamara (55695651200)
    ;
    Sprecher, Lawrence (57222489436)
    ;
    Dumic, Igor (57200701725)
    Suppurative portal vein thrombosis (pylephlebitis) is an uncommon condition usually associated with an intra-abdominal infection or inflammatory process. In this study, we aimed to synthesize data on previously published cases according to the PRISMA guidelines. A total of 103 patients were included. Patients were more commonly male (71.8%) and had a mean age of 49 years. The most common infection associated with pylephlebitis was diverticulitis (n = 29, 28.2%), and Escherichia coli was the most isolated pathogen (n = 21, 20.4%). Blood cultures were positive in 64 cases (62.1%). The most common site of thrombosis was the main portal vein (PV) in 59 patients (57.3%), followed by the superior mesenteric vein (SMV) in 40 patients (38.8%) and the right branch of the PV in 30 patients (29.1%). Sepsis developed in 60 patients (58.3%). The mortality rate in our review was 8.7%, and independent risk factors for mortality were the presence of pertinent comorbidities (OR 5.5, p = 0.02), positive blood cultures (OR 2.2, p = 0.02), and sepsis (OR 17.2, p = 0.049). © 2022 by the authors.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback